Revenues jump more than 2,000%, Cash up over 1,800%, Expanded product offerings gaining significant traction

LOS ANGELES, CA / ACCESSWIRE / April 21, 2022 / Cannabis Global, Inc. (OTC PINK:CBGL), a licensed Los Angeles-based manufacturer and distributor in the cannabis sector, is pleased to announce financial and operational performance data for the three months ended February 28, 2022.

“The past six months represents a breakthrough period for Cannabis Global on a relative basis,” noted Arman Tabatabaei, CEO of Cannabis Global. “We are beginning to see lift-off on our commercial-stage operational model, with extremely rapid topline growth, expanded product offerings, better funding terms, and more strategic opportunities. And all of it comes from the foundation we have put in place over recent years with our R&D focus and our strong IP orientation.”

Financial Performance Highlights for the Period Ended Feb 28, 2022

• Total Revenues for the three months ended Feb 28 were $627k, up 2,330% on a year-over-year basis
• Total Revenues for the six months ended Feb 28 were $1.2M, up 3,860% on a year-over-year basis
• Cash increased 1,860% year over year to $604k
• Total Assets increased 34% year over year to $15 million

Operational Highlights for the Period Ended Feb 28, 2022

• Signed definitive agreement with Caliwanna brands for comprehensive marketing and sales integration as well as to acquire Caliwanna cannabis brands
• Summarily restructured short-term convertible debt to reduce dilution risk and position company on more favorable capital terms
• Announced intention to apply for additional patent protection for its unique inventions for the creation of nanoparticles and nanofibers made for cannabinoids
• Laid foundation for the launch of an expanded suite of edibles products

Management notes that the Company has witnessed very strong topline revenue growth over the past two quarters as it ramps up commercial stage operations. That growth has been driven by a range of new products recently introduced into the marketplace as well as a widening of the Company’s distribution footprint. Revenue growth is also being driven by the Company’s acquisition of new customers in the retail dispensary space in California.

The Company has also benefited from revamping the Cannabis Global product mix to better reflect emerging trends in major California metro areas as these cannabis markets have matured. Management notes that its recent increased focus on the “solventless” trend has been an important factor, and the Company expects that trend to continue to be a key factor this year.

Tabatabaei added, “We have made some key acquisitions that will shape our performance ahead, which we believe will feature accelerating growth. However, we are also focused on establishing a more vertically integrated model so more of that growth goes straight to the bottom line as we scale up further over the year ahead.”

About Cannabis Global, Inc.
Cannabis Global, Inc. is a Los Angeles-based, fully audited and reporting Company with the U.S. Securities & Exchange Commission, trading under the stock symbol CBGL. We are an emerging force in the cannabis marketplace with a growing product and proprietary intellectual property portfolio. We are marketing and producing Comply Bag, an innovative solution for cannabis storage, transport and tracking. Our subsidiary, Natural Plant Extract (NPE), is a Southern California licensed cannabis manufacturer and distributor which licenses our technologies to produce edibles for the cannabis marketplace. Cannabis Global has filed three non-provisional and multiple provisional patents for cannabis infusion and nanoparticle technologies and continues an active research & development program.

Forward-Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

Corporate contact:
Arman Tabatabaei
[email protected]
+1 (310)-986-4929

IR Contact:
Stuart Smith
https://www.smallcapvoice.com/
[email protected]

SOURCE: Cannabis Global, Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

The global brand is working with LP to grow its consumer-focused product offerings.

Las Vegas, Nevada–(Newsfile Corp. – October 28, 2021) – Bhang Inc. (CSE: BHNG) (OTCQB: BHNGF) (“Bhang” or the “Company“), a global cannabis CPG brand company with an award-winning portfolio of products, has teamed up with California-based Lyfe Productives (“LP“) as part of the Company’s strategy to further develop and add to its THC edible offering.

LP is one of the top-five product development firms in the U.S., from the non-cannabis world, with clients in arts and culture, city planning, entertainment, and education. The firm specializes in connecting brands with specific audiences and is particularly well-known for its ability to build and develop product lines and brands from conception to commercialization.

“Our strategy is a three-legged stool,” says Bhang President and CEO, Jamie L. Pearson, “We are focused on winning the California market, expanding into new markets, and developing innovative and excellent products to capture more retail shelf space everywhere we’re located. We have solidified Bhang as one of the world’s leading cannabis brands, but as favorable legislation continues to roll out across the U.S. and into other countries, we look forward to blazing the trail in new subcategories, just as we have with our award-winning Bhang chocolates.”

In addition to product development, LP is also layering additional marketing and communication efforts to Bhang’s media mix. “They have their own marketing and social media channels,” says Jessica Hooper, Deputy Director at Lyfe Productives. “… but our agency is well-connected with budtenders, review sites, subscription box services and newsletters, allowing clients to skip past the draconian restrictions levied on cannabis companies. Bhang and LP are working together to manage the social buzz, and connect the brand directly to opted-in, highly-interested edibles consumers.”

Bhang retained Lyfe Productives to develop a specific set of products in 2021 and will be releasing details around these upcoming product initiatives in the coming months.

About Bhang

Bhang is committed to making the fairly enjoyable ridiculously fun. For over a decade Bhang has delivered exceptional sensory experiences to consumers through its extensive portfolio of over 50 master-chef-created cannabis, CBD and terpene products including gourmet chocolates, pre-rolls, CBD isolate, and Hempsticks. Bhang’s highly-awarded chocolates are among the top-selling edibles in 7 U.S. states and Canada. Bhang’s CBD products are globally distributed and are known for being safe, efficacious and delicious. Learn more at www.bhangnation.com and purchase our high-quality CBD products at www.bhangcbd.com.

About Lyfe Productives

Lyfe Productives is a product development, social marketing, and education firm focused on creating provocative products, messaging and outreach strategies for campaigns, programs, and brands to empower.

Companies, brands, city governments, and small businesses hire LP to make good ideas they’re conceiving happen in real life have a positive impact on society. Its clients include Mars Wrigley (KIND Bars), Kaiser Permanente, the National Fair Housing Alliance, The California Endowment, Comedy Central, The City of Oakland, Alameda County, University of California, Zendaya Coleman/Whalerock, and the Los Angeles Department of Transportation.

FORWARD-LOOKING STATEMENTS

This press release contains statements which constitute “forward‐looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities. Forward‐looking information is often identified by the words “may,” “would,” “could,” “should,” “will,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “expect” or similar expressions and include information regarding: (i) statements regarding the future direction of the Company; (ii) the ability of the Company to successfully achieve its business and financial objectives; (iii) plans for expansion of the Company into new jurisdictions; and (iv) expectations for other economic, business, and/or competitive factors. Investors are cautioned that forward‐looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning the business of the Company’s future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward‐looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements. Among the key factors that could cause actual results to differ materially from those projected in the forward‐looking information are the following: changes in general economic, business and political conditions, including changes in the financial markets; in particular, in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and hemp products in the markets that the Company operates in; adverse changes in applicable laws or adverse changes in the application or enforcement of current laws; the cannabis market is highly regulated and those regulations and enforcement priorities of governmental authorities may change; compliance with extensive government regulation and related costs; and other risks described in the Company’s Listing Statement, dated July 9, 2019, and other filings on www.sedar.com. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward‐looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward‐looking information except as otherwise required by applicable law.

Neither CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. ‎

Investors contact:
J. Graham Simmonds
Executive Chairman of the Board
Bhang Inc.
(416) 843-2881
[email protected]

Lyfe Productives Media contact:
Ise Lyfe
CEO
Lyfe Productives
(818)588-3008
[email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.